**U.S. nuclear explosive testing remains under a voluntary moratorium observed since 1992, with the United States relying on the Science-Based Stockpile Stewardship Program for warhead confidence.** President Trump’s late-2025 statements calling for tests “on an equal basis” with alleged foreign activities prompted market attention, yet administration officials quickly clarified that any steps would likely involve subcritical experiments or non-yield activities rather than full nuclear detonations. Preparation timelines of 24–36 months, Senate dynamics, CTBT norms, and risks of triggering reciprocal tests by Russia or China keep implied probabilities low across near-term resolution windows. Recent Pentagon work on penetrator munitions and microreactors reflects conventional and advanced nuclear infrastructure priorities rather than explosive testing plans. Traders price in these structural and diplomatic barriers while noting that only a presidential directive followed by rapid execution could shift outcomes before key deadlines.
Eksperimental na AI-generated summary na nire-reference ang Polymarket data. Hindi ito trading advice at wala itong papel sa kung paano nire-resolve ang market na ito. · Na-updateNuclear test ng US sa pamamagitan ng...?
Nuclear test ng US sa pamamagitan ng...?
$795,487 Vol.
Sep 30, 2026
Setyembre 30, 2026
1%
Disyembre 31, 2026
6%
$795,487 Vol.
Setyembre 30, 2026
$57,756 Vol.
1%
Disyembre 31, 2026
$76,920 Vol.
6%
This market will resolve to "Yes" if the US conducts a nuclear test by the listed date (ET). Otherwise, this market will resolve to "No".
A nuclear test is defined as the intentional non-combat detonation of a device by the US that produces a nuclear chain reaction (fission or fusion), regardless of yield.
Accidents, radiological dispersal devices (bombs that spread radioactive material using conventional explosives such as "dirty bombs"), or actions by third parties will not count toward this market's resolution.
Tests not explicitly claimed by US may still qualify if a clear consensus of credible reporting attributes the nuclear detonation to US. For example, an unclaimed nuclear test analogous to the 1979 "Vela Incident" would count if credible reporting attributes it to the US.
The resolution source for this market will be a broad consensus of credible reporting.**U.S. nuclear explosive testing remains under a voluntary moratorium observed since 1992, with the United States relying on the Science-Based Stockpile Stewardship Program for warhead confidence.** President Trump’s late-2025 statements calling for tests “on an equal basis” with alleged foreign activities prompted market attention, yet administration officials quickly clarified that any steps would likely involve subcritical experiments or non-yield activities rather than full nuclear detonations. Preparation timelines of 24–36 months, Senate dynamics, CTBT norms, and risks of triggering reciprocal tests by Russia or China keep implied probabilities low across near-term resolution windows. Recent Pentagon work on penetrator munitions and microreactors reflects conventional and advanced nuclear infrastructure priorities rather than explosive testing plans. Traders price in these structural and diplomatic barriers while noting that only a presidential directive followed by rapid execution could shift outcomes before key deadlines.
This market will resolve to "Yes" if the US conducts a nuclear test by the listed date (ET). Otherwise, this market will resolve to "No".
A nuclear test is defined as the intentional non-combat detonation of a device by the US that produces a nuclear chain reaction (fission or fusion), regardless of yield.
Accidents, radiological dispersal devices (bombs that spread radioactive material using conventional explosives such as "dirty bombs"), or actions by third parties will not count toward this market's resolution.
Tests not explicitly claimed by US may still qualify if a clear consensus of credible reporting attributes the nuclear detonation to US. For example, an unclaimed nuclear test analogous to the 1979 "Vela Incident" would count if credible reporting attributes it to the US.
The resolution source for this market will be a broad consensus of credible reporting.
A nuclear test is defined as the intentional non-combat detonation of a device by the US that produces a nuclear chain reaction (fission or fusion), regardless of yield.
Accidents, radiological dispersal devices (bombs that spread radioactive material using conventional explosives such as "dirty bombs"), or actions by third parties will not count toward this market's resolution.
Tests not explicitly claimed by US may still qualify if a clear consensus of credible reporting attributes the nuclear detonation to US. For example, an unclaimed nuclear test analogous to the 1979 "Vela Incident" would count if credible reporting attributes it to the US.
The resolution source for this market will be a broad consensus of credible reporting.
Binuksan ang Market: Mar 31, 2026, 3:32 PM ET
Volume
$795,487Petsa ng Pagtatapos
Jan 1, 2027Binuksan ang Market
Mar 31, 2026, 3:32 PM ETResolver
0x65070BE91...This market will resolve to "Yes" if the US conducts a nuclear test by the listed date (ET). Otherwise, this market will resolve to "No".
A nuclear test is defined as the intentional non-combat detonation of a device by the US that produces a nuclear chain reaction (fission or fusion), regardless of yield.
Accidents, radiological dispersal devices (bombs that spread radioactive material using conventional explosives such as "dirty bombs"), or actions by third parties will not count toward this market's resolution.
Tests not explicitly claimed by US may still qualify if a clear consensus of credible reporting attributes the nuclear detonation to US. For example, an unclaimed nuclear test analogous to the 1979 "Vela Incident" would count if credible reporting attributes it to the US.
The resolution source for this market will be a broad consensus of credible reporting.**U.S. nuclear explosive testing remains under a voluntary moratorium observed since 1992, with the United States relying on the Science-Based Stockpile Stewardship Program for warhead confidence.** President Trump’s late-2025 statements calling for tests “on an equal basis” with alleged foreign activities prompted market attention, yet administration officials quickly clarified that any steps would likely involve subcritical experiments or non-yield activities rather than full nuclear detonations. Preparation timelines of 24–36 months, Senate dynamics, CTBT norms, and risks of triggering reciprocal tests by Russia or China keep implied probabilities low across near-term resolution windows. Recent Pentagon work on penetrator munitions and microreactors reflects conventional and advanced nuclear infrastructure priorities rather than explosive testing plans. Traders price in these structural and diplomatic barriers while noting that only a presidential directive followed by rapid execution could shift outcomes before key deadlines.
This market will resolve to "Yes" if the US conducts a nuclear test by the listed date (ET). Otherwise, this market will resolve to "No".
A nuclear test is defined as the intentional non-combat detonation of a device by the US that produces a nuclear chain reaction (fission or fusion), regardless of yield.
Accidents, radiological dispersal devices (bombs that spread radioactive material using conventional explosives such as "dirty bombs"), or actions by third parties will not count toward this market's resolution.
Tests not explicitly claimed by US may still qualify if a clear consensus of credible reporting attributes the nuclear detonation to US. For example, an unclaimed nuclear test analogous to the 1979 "Vela Incident" would count if credible reporting attributes it to the US.
The resolution source for this market will be a broad consensus of credible reporting.
A nuclear test is defined as the intentional non-combat detonation of a device by the US that produces a nuclear chain reaction (fission or fusion), regardless of yield.
Accidents, radiological dispersal devices (bombs that spread radioactive material using conventional explosives such as "dirty bombs"), or actions by third parties will not count toward this market's resolution.
Tests not explicitly claimed by US may still qualify if a clear consensus of credible reporting attributes the nuclear detonation to US. For example, an unclaimed nuclear test analogous to the 1979 "Vela Incident" would count if credible reporting attributes it to the US.
The resolution source for this market will be a broad consensus of credible reporting.
Volume
$795,487Petsa ng Pagtatapos
Jan 1, 2027Binuksan ang Market
Mar 31, 2026, 3:32 PM ETResolver
0x65070BE91...**U.S. nuclear explosive testing remains under a voluntary moratorium observed since 1992, with the United States relying on the Science-Based Stockpile Stewardship Program for warhead confidence.** President Trump’s late-2025 statements calling for tests “on an equal basis” with alleged foreign activities prompted market attention, yet administration officials quickly clarified that any steps would likely involve subcritical experiments or non-yield activities rather than full nuclear detonations. Preparation timelines of 24–36 months, Senate dynamics, CTBT norms, and risks of triggering reciprocal tests by Russia or China keep implied probabilities low across near-term resolution windows. Recent Pentagon work on penetrator munitions and microreactors reflects conventional and advanced nuclear infrastructure priorities rather than explosive testing plans. Traders price in these structural and diplomatic barriers while noting that only a presidential directive followed by rapid execution could shift outcomes before key deadlines.
Eksperimental na AI-generated summary na nire-reference ang Polymarket data. Hindi ito trading advice at wala itong papel sa kung paano nire-resolve ang market na ito. · Na-update
Mag-ingat sa mga external link.
Mag-ingat sa mga external link.
Mga Madalas na Tanong